Chemerin as a Biomarker for Periodontitis in Systemically Healthy and Type 2 Diabetic Patients
DOI:
https://doi.org/10.32828/mdj.v18i2.920Keywords:
Chemerin, Periodontitis, Type 2 Diabetes MellitusAbstract
Aim of the study: The aim of the study was to evaluate the salivary levels of chemerin in patients with periodontitis and type 2 diabetes mellitus.
Materials and methods: A total of 88 subjects were divided into four groups; 13 systemically healthy individuals having a healthy periodontium (control group), 25 patients with type 2 diabetes mellitus and healthy periodontium (T2DM group), 25 patients with generalized periodontitis (P group), 25 patients with generalized periodontitis and type 2 diabetes mellitus (P-T2DM group). The clinical periodontal parameters including plaque index (PLI), bleeding on probing (BOP), probing pocket depth (PPD), and clinical attachment loss (CAL) were determined. Unstimulated saliva was gathered, and the concentration of chemerin was estimated utilizing an enzyme-linked immunosorbent assay.
Results: The results showed that the mean concentrations of chemerin were highest in the P-T2DM group with a mean (of 1.598±0.1499 ng/ml) followed by the P group (1.445±0.1021 ng/ml), T2DM group (1.368±0.096 ng/ml), and control group (1.229±0.152 ng/ml), respectively. There was a statistically significant difference among groups at (p<0.05). For the correlation of chemerin with clinical periodontal parameters, chemerin correlated with PPD in the P group at p= 0.014, and chemerin correlated with clinical periodontal parameters PLI, BOP, and PPD in the P-T2DM group at (p=0.006, p< 0.000, p=0.035), respectively.
Conclusion: Periodontitis and type 2 diabetes mellitus caused an increase in salivary chemerin concentration, which might be used as a marker for both diabetes and periodontitis.
References
Salman, Z., Ghudhaib, K., Fadhil, R. Evaluating Osteocalcin and Osteonectin in serum male patients with type 2 Diabetes mellitus and periodontitis. Eurasian Chemical Communications, 2022; 4(4): 295-302.
Meyle J, Chapple I. Molecular aspects of the pathogenesis of periodontitis. Periodontology 2000. 2015 Oct;69(1):7-17.
Balaky HM, Kakey IS. The Key Role of Bone Function Markers in Patients with Type (II) Diabetes Mellitus. Iraqi Journal of Science. 2022 Jul 31:2861-72.
American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2020. Diabetes care. 2020 Jan 1;43(Supplement_1):S14-31.
Chee B, Park B, Bartold PM. Periodontitis and type II diabetes: a two‐way relationship. International Journal of Evidence‐based Healthcare. 2013 Dec;11(4):317-29.
Amr E, Mostafa R, Shaker O. Possible role of gingival crevicular fluid levels of Chemerin and Fibroblast growth factor 21 as biomarkers of periodontal disease in diabetic and non-diabetic patients. A diagnostic accuracy study. Advanced Dental Journal. 2019 Jul 1;1(2):52-63.
Shin WJ, Zabel BA, Pachynski RK. Mechanisms and functions of chemerin in cancer: potential roles in therapeutic intervention. Frontiers in immunology. 2018 Nov 30;9:2772.
Bondue B, Wittamer V, Parmentier M. Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine & growth factor reviews. 2011 Oct 1;22(5-6):331-8.
Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, Brézillon S, Tyldesley R, Blanpain C, Detheux M, Mantovani A. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. The Journal of experimental medicine. 2003 Oct 6;198(7):977-85.
Hart R, Greaves DR. Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. The Journal of Immunology. 2010 Sep 15;185(6):3728-39.
Özcan E, Işıl Saygun N, Serdar MA, Umut Bengi V, Kantarcı A. Non‐surgical periodontal therapy reduces saliva adipokine and matrix metalloproteinase levels in periodontitis. Journal of periodontology. 2016 Aug;87(8):934-43.
Consultation WE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (London, England). 2004 Jan 10;363(9403):157-63.
Chapple IL, Mealey BL, Van Dyke TE, Bartold PM, Dommisch H, Eickholz P, Geisinger ML, Genco RJ, Glogauer M, Goldstein M, Griffin TJ. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri‐Implant Diseases and Conditions. Journal of periodontology. 2018 Jun;89:S74-84.
Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. Journal of periodontology. 2018 Jun;89:S159-72.
O'LEARY TJ. The plaque control record. J. Periodontol.. 1972;43:38.
Newman MG, Takei H, Klokkevold PR, Carranza FA. Newman and Carranza's Clinical periodontology E-book. Elsevier Health Sciences; 2018 May 29.
Özcan E, Saygun NI, Serdar MA, Kurt N. Evaluation of the salivary levels of visfatin, chemerin, and progranulin in periodontal inflammation. Clinical oral investigations. 2015 May;19(4):921-8.
Yoshimura T, Oppenheim JJ. Chemokine-like receptor 1 (CMKLR1) and chemokine (C–C motif) receptor-like 2 (CCRL2); Two multifunctional receptors with unusual properties. Experimental cell research. 2011 Mar 10;317(5):674-84.
Berg V, Sveinbjörnsson B, Bendiksen S, Brox J, Meknas K, Figenschau Y. Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin21-157. Arthritis research & therapy. 2010 Dec;12(6):1-2.
Gomes FI, Aragão MG, Barbosa FC, Bezerra MM, Pinto VD, Chaves HV. Inflammatory cytokines interleukin-1β and tumour necrosis factor-α-novel biomarkers for the detection of periodontal diseases: a literature review. Journal of oral & maxillofacial research. 2016 Apr;7(2).
Xue Y, Jiang L, Cheng Q, Chen H, Yu Y, Lin Y, Yang X, Kong N, Zhu X, Xu X, Wan W. Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. PLoS One. 2012 Oct 29;7(10):e46740.
Ameen EM, Mohammed HY. Correlation between Tumor Necrosis Factor–Alfa and Anti-tyrosine Phosphatase with Obesity and Diabetes Type 2. Iraqi Journal of Science. 2022 Aug 31:3322-31.
Bobbert T, Schwarz F, Fischer‐Rosinsky A, Maurer L, Möhlig M, Pfeiffer AF, Mai K, Spranger J. Chemerin and prediction of Diabetes mellitus type 2. Clinical endocrinology. 2015 Jun;82(6):838-43.
Himanshu Aeran, Amrinder Singh Tuli, Rebecca Chowdhry, Anissa Atif Mirza, Raman Kumar, Basant Kaur Aulakh. Effect of non-surgical periodontal therapy on salivary resistin and chemerin levels in type 2 diabetes mellitus with chronic periodontitis. International Journal of Oral Health Dentistry, 2022,8(2):128–134.
Doğan ŞB, Ballı U, Dede FÖ, Sertoğlu E, Tazegül K. Chemerin as a novel crevicular fluid marker of patients with periodontitis and type 2 diabetes mellitus. Journal of periodontology. 2016 Aug;87(8):923-33.
Patnaik K, Pradeep AR, Nagpal K, Karvekar S, Singh P, Raju A. Human chemerin correlation in gingival crevicular fluid and tear fluid as markers of inflammation in chronic periodontitis and type‐2 diabetes mellitus. Journal of Investigative and Clinical Dentistry. 2017 Feb;8(1):e12181.
Taiyeb‐Ali TB, Raman RP, Vaithilingam RD. Relationship between periodontal disease and diabetes mellitus: an Asian perspective. Periodontology 2000. 2011 Jun;56(1):258-68.
Abdul-wahab GA, Ahmed MA. Assessment of Some Salivary Enzymes Levels in Type 2 Diabetic Patients with Chronic Periodontitis: Clinical and Biochemical Study. Journal of baghdad college of dentistry. 2015 Mar;325(2218):1-3.
Hassan RS, Salman SA. Evaluation of Salivary Melatonin and Periodontal Parameters in Type II Diabetic Patients with Chronic Periodontitis: A Comparative Study. Indian Journal of Public Health Research & Development. 2019 Oct 1;10(10).
Serrano C, Perez C, Rodríguez M. Periodontal conditions in a group of Colombian type 2 diabetic patients with different degrees of metabolic control. Acta odontológica latinoamericana. 2012 Apr;25(1):130-7.
Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontology 2000. 1997 Jun;14(1):33-53.
Kumar MS, Vamsi G, Sripriya R, Sehgal PK. Expression of matrix metalloproteinases (MMP‐8 and‐9) in chronic periodontitis patients with and without diabetes mellitus. Journal of periodontology. 2006 Nov;77(11):1803-8.
Hintao J, Teanpaisan R, Chongsuvivatwong V, Ratarasan C, Dahlen G. The microbiological profiles of saliva, supragingival and subgingival plaque and dental caries in adults with and without type 2 diabetes mellitus. Oral microbiology and immunology. 2007 Jun;22(3):175-81.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Mustansiria Dental Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International License.
